CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 

Amgen Inc 's Long Term Debt to Equity

AMGN's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




AMGN Long Term Debt to Equity (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Equity Change -22.63 % -1.59 % -2.73 % 0.29 % -1.25 %
Y / Y Long Term Debt Change -16.63 % 3.74 % 22.06 % 23.26 % 22.79 %
Long Term Debt to Equity MRQ 3.45 3.34 3.5 3.12 3.2
Overall Ranking # # # # #
Seq. Equity Change -11.65 % -0.8 % -14.14 % 2.81 % 12.38 %
Seq. Long Term Debt Change -8.58 % -5.37 % -3.8 % 0.18 % 13.75 %



Long Term Debt to Equity second quarter 2021 Comment
Despite long-term debt repayement of -8.58%, in II. Quarter ,Long Term Debt to Equity detoriated to 3.45, above company's average Long Term Debt to Equity.

Within Biotechnology & Pharmaceuticals industry in the second quarter 2021, 63 other companies have achieved lower Long Term Debt to Equity than Amgen Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
Learn more about AMGN
Long Term Debt to Equity Ratio AMGN on the trailing twelve month basis
Long Term Debt to Equity second quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 64
Healthcare Sector # 339
Overall Market # 2503


Long Term Debt to Equity Statistics
High Average Low
3.5 1.03 0.01
(Dec 31 2020)   (Sep. 30, 2004)




Financial Statements
Amgen Inc 's Equity $ 8,247 Millions Visit AMGN's Balance sheet
Amgen Inc 's Long Term Debt $ 28,458 Millions Visit AMGN's Balance sheet
Source of AMGN's Sales Visit AMGN's Sales by Geography




Companies with similar Long Term Debt to Equity in the quarter endingJun 30 2021, within Biotechnology & Pharmaceuticals Industry Long Term Debt to EquityJun 30 2021 MRQ Long Term DebtJun 30 2021 MRQ Equity
Halozyme Therapeutics Inc   6.56 $ 785.571  Millions$ 119.748  Millions
Abbvie Inc   5.89 $ 74,237.000  Millions$ 12,594.000  Millions
Axim Biotechnologies Inc   5.36 $ 5.565  Millions$ 1.038  Millions
Pactiv Evergreen Inc   3.82 $ 3,918.000  Millions$ 1,025.000  Millions
Amgen Inc   3.45 $ 28,458.000  Millions$ 8,247.000  Millions
Avantor Inc   1.88 $ 5,611.500  Millions$ 2,985.900  Millions
Coherus Biosciences inc   1.84 $ 287.075  Millions$ 156.220  Millions
Genocea Biosciences Inc   1.60 $ 6.494  Millions$ 4.055  Millions
Inhibrx Inc   1.57 $ 69.670  Millions$ 44.319  Millions
Gilead Sciences Inc   1.42 $ 27,914.000  Millions$ 19,710.000  Millions
Reynolds Consumer Products Inc   1.25 $ 2,097.000  Millions$ 1,676.000  Millions
Nanostring Technologies Inc   1.02 $ 224.424  Millions$ 219.727  Millions
Aziyo Biologics inc   0.91 $ 13.682  Millions$ 14.967  Millions
Acorda Therapeutics inc   0.90 $ 172.327  Millions$ 190.481  Millions
Adma Biologics Inc   0.84 $ 93.877  Millions$ 111.594  Millions
Allena Pharmaceuticals Inc   0.81 $ 9.880  Millions$ 12.267  Millions
Cerecor Inc   0.79 $ 17.143  Millions$ 21.588  Millions
Eyenovia inc   0.78 $ 6.995  Millions$ 8.991  Millions
Evelo Biosciences Inc   0.75 $ 46.482  Millions$ 62.093  Millions
Establishment Labs Holdings Inc   0.74 $ 50.810  Millions$ 68.829  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CULP's Profile

Stock Price

CULP's Financials

Business Description

Fundamentals

Charts & Quotes

CULP's News

Suppliers

CULP's Competitors

Customers & Markets

Economic Indicators

CULP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071